| What causes psychosis? An umbrella review of risk and protective factors J Radua, V Ramella‐Cravaro, JPA Ioannidis, A Reichenberg, ... World psychiatry 17 (1), 49-66, 2018 | 750 | 2018 |
| Transdiagnostic psychiatry: a systematic review P Fusar‐Poli, M Solmi, N Brondino, C Davies, C Chae, P Politi, ... World Psychiatry 18 (2), 192-207, 2019 | 530 | 2019 |
| Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis C Davies, G Segre, A Estradé, J Radua, A De Micheli, U Provenzani, ... The Lancet Psychiatry 7 (5), 399-410, 2020 | 349 | 2020 |
| Development and validation of a clinically based risk calculator for the transdiagnostic prediction of psychosis P Fusar-Poli, G Rutigliano, D Stahl, C Davies, I Bonoldi, T Reilly, ... JAMA psychiatry 74 (5), 493-500, 2017 | 309 | 2017 |
| Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis C Davies, A Cipriani, JPA Ioannidis, J Radua, D Stahl, U Provenzani, ... World Psychiatry 17 (2), 196-209, 2018 | 270 | 2018 |
| Cannabis-associated psychosis: Neural substrate and clinical impact RM Murray, A Englund, A Abi-Dargham, DA Lewis, M Di Forti, C Davies, ... Neuropharmacology 124, 89-104, 2017 | 251 | 2017 |
| What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors D Oliver, TJ Reilly, O Baccaredda Boy, N Petros, C Davies, S Borgwardt, ... Schizophrenia bulletin 46 (1), 110-120, 2020 | 212 | 2020 |
| Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies D Oliver, C Davies, G Crossland, S Lim, G Gifford, P McGuire, ... Schizophrenia bulletin 44 (6), 1362-1372, 2018 | 147 | 2018 |
| Cannabidiol as a potential treatment for psychosis C Davies, S Bhattacharyya Therapeutic advances in psychopharmacology 9, 2045125319881916, 2019 | 145 | 2019 |
| Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders P Fusar-Poli, G Rutigliano, D Stahl, C Davies, A De Micheli, ... European Psychiatry 42, 49-54, 2017 | 144 | 2017 |
| Efficacy and acceptability of interventions for attenuated positive psychotic symptoms in individuals at clinical high risk of psychosis: a network meta-analysis C Davies, J Radua, A Cipriani, D Stahl, U Provenzani, P McGuire, ... Frontiers in Psychiatry 9, 187, 2018 | 126 | 2018 |
| Preventive treatments for psychosis: umbrella review (just the evidence) P Fusar-Poli, C Davies, M Solmi, N Brondino, A De Micheli, ... Frontiers in Psychiatry 10, 460288, 2019 | 120 | 2019 |
| Transdiagnostic risk calculator for the automatic detection of individuals at risk and the prediction of psychosis: second replication in an independent national health service … P Fusar-Poli, N Werbeloff, G Rutigliano, D Oliver, C Davies, D Stahl, ... Schizophrenia Bulletin 45 (3), 562-570, 2019 | 119 | 2019 |
| GABA, Glutamate and Neural Activity: A Systematic Review With Meta-Analysis of Multimodal 1H-MRS-fMRI Studies A Kiemes, C Davies, MJ Kempton, PB Lukow, C Bennallick, JM Stone, ... Frontiers in psychiatry 12, 644315, 2021 | 77 | 2021 |
| Why transition risk to psychosis is not declining at the OASIS ultra high risk service: the hidden role of stable pretest risk enrichment P Fusar-Poli, E Palombini, C Davies, D Oliver, I Bonoldi, ... Schizophrenia Research 192, 385-390, 2018 | 64 | 2018 |
| Long term outcomes of acute and transient psychotic disorders: the missed opportunity of preventive interventions G Rutigliano, S Merlino, A Minichino, R Patel, C Davies, D Oliver, ... European Psychiatry 52, 126-133, 2018 | 51 | 2018 |
| Unmet needs in patients with brief psychotic disorders: too ill for clinical high risk services and not ill enough for first episode services A Minichino, G Rutigliano, S Merlino, C Davies, D Oliver, A De Micheli, ... European Psychiatry 57, 26-32, 2019 | 48 | 2019 |
| Diagnostic and prognostic significance of DSM-5 attenuated psychosis syndrome in services for individuals at ultra high risk for psychosis P Fusar-Poli, A De Micheli, M Cappucciati, G Rutigliano, C Davies, ... Schizophrenia bulletin 44 (2), 264-275, 2018 | 45 | 2018 |
| The Yin and Yang of Cannabis: a systematic review of human neuroimaging evidence of the differential effects of Δ9-tetrahydrocannabinol and cannabidiol B Gunasekera, C Davies, R Martin-Santos, S Bhattacharyya Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 6 (6), 636-645, 2021 | 44 | 2021 |
| A single dose of cannabidiol modulates medial temporal and striatal function during fear processing in people at clinical high risk for psychosis C Davies, R Wilson, E Appiah-Kusi, G Blest-Hopley, M Brammer, J Perez, ... Translational Psychiatry 10 (1), 311, 2020 | 40 | 2020 |
Fusar-Poli PaoloPrimary: King's College London, UK; Secondary: University of Pavia, ItalyVerified email at kcl.ac.uk
